# EDGAR Filing Document

**Accession Number:** 0001427570
**File Stem:** 0001104659-25-070442
**Filing Date:** 2025-7
**Character Count:** 3207
**Document Hash:** e8b23ff2e22544b8caa8ce06800ad24d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-070442.hdr.sgml**: 20250724

**ACCESSION NUMBER**: 0001104659-25-070442

**CONFORMED SUBMISSION TYPE**: 425

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250724

**DATE AS OF CHANGE**: 20250724

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ReShape Lifesciences Inc.
- **CENTRAL INDEX KEY:** 0001427570
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 425
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37897
- **FILM NUMBER:** 251147951

**BUSINESS ADDRESS:**
- **STREET 1:** 1001 CALLE AMANECER
- **CITY:** SAN CLEMENTE
- **STATE:** CA
- **ZIP:** 92673
- **BUSINESS PHONE:** 949-429-6680

**MAIL ADDRESS:**
- **STREET 1:** 1001 CALLE AMANECER
- **CITY:** SAN CLEMENTE
- **STATE:** CA
- **ZIP:** 92673

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** OBALON THERAPEUTICS INC
- **DATE OF NAME CHANGE:** 20080220
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ReShape Lifesciences Inc.
- **CENTRAL INDEX KEY:** 0001427570
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 425

**BUSINESS ADDRESS:**
- **STREET 1:** 1001 CALLE AMANECER
- **CITY:** SAN CLEMENTE
- **STATE:** CA
- **ZIP:** 92673
- **BUSINESS PHONE:** 949-429-6680

**MAIL ADDRESS:**
- **STREET 1:** 1001 CALLE AMANECER
- **CITY:** SAN CLEMENTE
- **STATE:** CA
- **ZIP:** 92673

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** OBALON THERAPEUTICS INC
- **DATE OF NAME CHANGE:** 20080220

**Filed by ReShape Lifesciences Inc.**

 **pursuant to Rule 425 under the Securities Act of 1933**

**and deemed filed pursuant to Rule 14a-12**

**under the Securities Exchange Act of 1934**

**Subject Company: ReShape Lifesciences Inc.**

**Commission File No.: 001-37897**

![](tm2521354d3_425img01.jpg)

**IMPORTANT ALERT**

**We adjourned the Special Meeting to approve our transaction with Vyome Therapeutics to August 7<sup>th</sup> to provide more time for ReShape shareholders to vote on Proposals 2 & 3.**

Proposal 2 (approval of proposed asset sale) and Proposal 3 (approval of proposed charter amendment) each require the affirmative vote of a majority of the outstanding shares. **Not voting will have the same effect as a vote *against* Proposals 2 & 3.**

***PLEASE DO NOT DELAY--VOTING IS QUICK AND EASY!***

Our proxy solicitor, Innisfree, can take your vote directly by phone or

help with any questions that you may have about the Special Meeting. Please call:

**Toll-free: (877) 717-3905 (from the U.S and Canada) or**

**+1 (412) 232-3651 (from other locations)**

**10:00 am-7:00 pm ET, Monday-Friday; 10:00am-2:00pm ET, Saturday**

![](tm2521354d3_425img01.jpg)

**TIME IS SHORT—PLEASE DO NOT DELAY!**

**PLEASE CALL TODAY TO VOTE BY TELEPHONE**

**OR FOR HELP WITH ANY QUESTIONS**

**YOU MAY HAVE ABOUT THE SPECIAL MEETING.**

*(SEE REVERSE FOR VOTING DETAILS)*